Cipla set to buy American business of Hetero Drugs for $550 million
MUMBAI (TIP): India’s third-largest drug maker Cipla is buying the American business of Hyderabad-based Hetero Drugs as it seeks to expand its fledgling presence in the world’s biggest pharma market. People close to the transaction […]
